Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Triaminic Severe Cold and Flu

This article was originally published in The Tan Sheet

Executive Summary

Four-ingredient analgesic/cough/cold line extension being introduced for the cough/cold season, backed by TV, print and FSI advertising. The bubble gum-colored and -flavored syrup contains acetaminophen, dextromethorphan, pseudoephedrine and chlorpheniramine; it will be priced in line with other category products. Novartis also plans to introduce a Triaminic product this year that employs Cima Labs' Orasolv fast-dissolving dosage technology. The technology is used in Bristol-Myers Squibb's Tempra pediatric acetaminophen analgesic...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088657

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel